These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 24423357

  • 1. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ, Kagan R, Altomare CJ, Komm B, Mirkin S, Taylor HS.
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [Abstract] [Full Text] [Related]

  • 2. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S, Komm BS.
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [Abstract] [Full Text] [Related]

  • 3. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
    Smith CL, Santen RJ, Komm B, Mirkin S.
    Breast Cancer Res; 2014 Jun 18; 16(3):212. PubMed ID: 25928299
    [Abstract] [Full Text] [Related]

  • 4. Emerging hormonal treatments for menopausal symptoms.
    Genazzani AR, Komm BS, Pickar JH.
    Expert Opin Emerg Drugs; 2015 Mar 18; 20(1):31-46. PubMed ID: 25557757
    [Abstract] [Full Text] [Related]

  • 5. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV, Thomas S.
    J Steroid Biochem Mol Biol; 2014 Jul 18; 142():142-54. PubMed ID: 24373794
    [Abstract] [Full Text] [Related]

  • 6. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH, Mirkin S.
    Menopause Int; 2010 Sep 18; 16(3):121-8. PubMed ID: 20956688
    [Abstract] [Full Text] [Related]

  • 7. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Sep 18; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 8. What do TSECs provide in the menopausal hormone therapy?
    Llaneza P, Calaf J, Jurado AR, Mendoza N, Otero B, Quereda F, Sánchez-Borrego R, Lubian D.
    Gynecol Endocrinol; 2018 Oct 18; 34(10):826-832. PubMed ID: 29790381
    [Abstract] [Full Text] [Related]

  • 9. Tissue selective estrogen complex (TSEC): a review.
    Pickar JH, Boucher M, Morgenstern D.
    Menopause; 2018 Sep 18; 25(9):1033-1045. PubMed ID: 29533367
    [Abstract] [Full Text] [Related]

  • 10. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A.
    J Am Assoc Nurse Pract; 2013 Mar 18; 25(3):126-33. PubMed ID: 24218199
    [Abstract] [Full Text] [Related]

  • 11. The endometrium--from estrogens alone to TSECs.
    Pickar JH.
    Climacteric; 2009 Dec 18; 12(6):463-77. PubMed ID: 19905899
    [Abstract] [Full Text] [Related]

  • 12. An overview of current and emerging SERMs.
    Komm BS, Mirkin S.
    J Steroid Biochem Mol Biol; 2014 Sep 18; 143():207-22. PubMed ID: 24667357
    [Abstract] [Full Text] [Related]

  • 13. Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.
    Archer DF.
    Drugs Aging; 2010 Jul 01; 27(7):533-44. PubMed ID: 20583848
    [Abstract] [Full Text] [Related]

  • 14. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S, Ryan KA, Chandran AB, Komm BS.
    Maturitas; 2014 Jan 01; 77(1):24-31. PubMed ID: 24246155
    [Abstract] [Full Text] [Related]

  • 15. Evolution of the tissue selective estrogen complex (TSEC).
    Komm BS, Mirkin S.
    J Cell Physiol; 2013 Jul 01; 228(7):1423-7. PubMed ID: 23359290
    [Abstract] [Full Text] [Related]

  • 16. Preventing osteoporosis in symptomatic postmenopausal women.
    Gallagher JC, Levine JP.
    Menopause; 2011 Jan 01; 18(1):109-18. PubMed ID: 20661164
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of menopausal therapies on the endometrium.
    Mirkin S, Archer DF, Taylor HS, Pickar JH, Komm BS.
    Menopause; 2014 Aug 01; 21(8):899-908. PubMed ID: 24518153
    [Abstract] [Full Text] [Related]

  • 18. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
    Kloosterboer HJ, Ederveen AG.
    J Steroid Biochem Mol Biol; 2002 Dec 01; 83(1-5):157-65. PubMed ID: 12650712
    [Abstract] [Full Text] [Related]

  • 19. SERMs: progress and future perspectives.
    Pickar JH, MacNeil T, Ohleth K.
    Maturitas; 2010 Oct 01; 67(2):129-38. PubMed ID: 20580502
    [Abstract] [Full Text] [Related]

  • 20. A new approach to menopausal therapy: the tissue selective estrogen complex.
    Komm BS.
    Reprod Sci; 2008 Dec 01; 15(10):984-92. PubMed ID: 19088368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.